For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain ...
May 28, 2013
0
0
There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg ...
May 20, 2013
1
1
Women admitted to psychiatry wards experience high levels of violence and sexual assaults, according to a report released this week by the Victorian Mental Illness Alliance Council.
May 17, 2013
0
0
Americans are over-diagnosed and over-treated for depression, according to a new study conducted at the Johns Hopkins Bloomberg School of Public Health. The study examines adults with clinician-identified depression and individuals ...
Apr 30, 2013
0
0
Among infants with neonatal abstinence syndrome (NAS; caused by in utero opioid exposure), variants in certain genes were associated with a shorter length of hospital stay and less need for treatment, preliminary findings ...
Apr 30, 2013
0
0
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study ...
Apr 23, 2013
0
0
(Medical Xpress)—Researchers have found a new method for studying depression in rats that mirrors an aspect of the mood-related symptoms of the condition in humans. Until now, the lack of animal models that can replicate ...
Apr 19, 2013
0
0
(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated with these ...
Apr 15, 2013
0
1
(Medical Xpress)—Researchers in Scotland and Germany have discovered a molecular mechanism that shows promise for developing a cure for Huntington's Disease (HD).
Feb 27, 2013
0
0
A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving ...
Feb 20, 2013
0
0
